Rhabdomysarcoma and combined treatment in oral and maxillofacial regions.
- Author:
Ge FENG
1
;
Da-zhang WANG
;
Guang-yong ZHENG
;
Jia HE
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; therapeutic use; Child; Child, Preschool; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Infant; Jaw Neoplasms; pathology; surgery; therapy; Male; Middle Aged; Mouth Neoplasms; pathology; surgery; therapy; Radiotherapy, Adjuvant; Rhabdomyosarcoma; pathology; surgery; therapy; Rhabdomyosarcoma, Embryonal; pathology; surgery; therapy; Survival Rate; Treatment Outcome
- From: West China Journal of Stomatology 2004;22(2):129-131
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo study the treatment outcome of rhabdomysarcoma(RMS).
METHODS74 cases of RMS with definite pathologic diagnosis treated in our department during the past 20 years were investigated. The relationship between the therapy and prognosis was analyzed.
RESULTS52 cases among the 74 patients received different surgical treatment and post-operative radiotherapy. 22 cases received radiotherapy or chemoradiotherapy without surgical treatment. The survival rates demonstrated great differences depending on the different clinical stages and therapy.
CONCLUSIONThe combined therapy including radiotherapy after surgical treatment may increase 5-year survival rate.
